相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiometabolic profile of young women with hypoprolactinemia
Robert Krysiak et al.
ENDOCRINE (2022)
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence
Salvatore Giovinazzo et al.
PITUITARY (2021)
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
Rosa Pirchio et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study
Anna Sophia Posawetz et al.
BMC ENDOCRINE DISORDERS (2021)
Is there an increased cardiovascular risk in patients with prolactinoma? A challenging question
Dilek Yazici et al.
JOURNAL OF CLINICAL ULTRASOUND (2021)
Hyperprolactinemia after menopause: Diagnosis and management
Renata S. Auriemma et al.
MATURITAS (2021)
Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term
Lukas Andereggen et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2021)
Prolactinomas and menopause: any changes in management?
Yona Greenman
PITUITARY (2020)
Obesity is common at diagnosis of childhood pituitary adenoma and may persist following successful treatment
Aashish Sethi et al.
CLINICAL ENDOCRINOLOGY (2020)
Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake
Felicitas Lopez-Vicchi et al.
FASEB JOURNAL (2020)
Time for a New Perspective on Prolactin in Metabolism
Yazmin Macotela et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Dopamine Agonists: From the 1970s to Today
Renata S. Auriemma et al.
NEUROENDOCRINOLOGY (2019)
Glucose Abnormalities Associated to Prolactin Secreting Pituitary Adenomas
Renata S. Auriemma et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Markers of Metabolic Syndrome in Patients with Pituitary Adenoma: A Case Series of 303 Patients
Seher Cetinkaya Altuntas et al.
HORMONE AND METABOLIC RESEARCH (2019)
An investigation of the association between the level of prolactin in serum and type II diabetes
Najmeh Manshaei et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Prolactin improves hepatic steatosis via CD36 pathway
Pengzi Zhang et al.
JOURNAL OF HEPATOLOGY (2018)
Novel Trajectories of Bromocriptine Antidiabetic Action: Leptin-IL-6/JAK2/p-STAT3/SOCS3, p-IR/p-AKT/GLUT4, PPAR-γ/Adiponectin, Nrf2/PARP-1, and GLP-1
Enji Reda et al.
FRONTIERS IN PHARMACOLOGY (2018)
Circulating prolactin concentrations and risk of type 2 diabetes in US women
Jun Li et al.
DIABETOLOGIA (2018)
The effects of hyperprolactinemia and its control on metabolic diseases
Renata S. Auriemma et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2018)
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
Verena Schwetz et al.
METABOLIC BRAIN DISEASE (2017)
Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause
G. Georgiopoulos et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes
Ravi Retnakaran et al.
DIABETES CARE (2016)
Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial
Adele Bahar et al.
MEDICINE (2016)
Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia
Milica Medic-Stojanoska et al.
MEDICAL HYPOTHESES (2015)
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas
Renata S. Auriemma et al.
NEUROENDOCRINOLOGY (2015)
Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
Nazir A. Pala et al.
DIABETOLOGY & METABOLIC SYNDROME (2015)
Associations Between Circulating Reproductive Hormones and SHBG and Prevalent and Incident Metabolic Syndrome in Community-Dwelling Older Men: The Concord Health and Ageing in Men Project
Benjumin Hsu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Low Prolactin Is Associated with Sexual Dysfunction and Psychological or Metabolic Disturbances in Middle-Aged and Elderly Men: The European Male Aging Study (EMAS)
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Successful Diet and Exercise Therapy as Evaluated on Self-Assessment Score Significantly Improves Endothelial Function in Metabolic Syndrome Patients
Yasushi Matsuzawa et al.
CIRCULATION JOURNAL (2013)
Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction
Valeria Chirico et al.
CLINICAL ENDOCRINOLOGY (2013)
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels
Alessandro Ciresi et al.
CLINICAL ENDOCRINOLOGY (2013)
Circulating Prolactin Associates With Diabetes and Impaired Glucose Regulation A population-based study
Tiange Wang et al.
DIABETES CARE (2013)
Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study
E. M. Camacho et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Effect of Cabergoline on Metabolism in Prolactinomas
Renata S. Auriemma et al.
NEUROENDOCRINOLOGY (2013)
Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?
Lisa Balbach et al.
BMC ENDOCRINE DISORDERS (2013)
Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia
Aysegul Atmaca et al.
ENDOCRINE (2013)
Low circulating IGF-I bioactivity is associated with human longevity: Findings in centenarians' offspring
Giovanni Vitale et al.
AGING-US (2012)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
BMI and Metabolic Profile in Patients With Prolactinoma Before and After Treatment With Dopamine Agonists
Cintia M. dos Santos Silva et al.
OBESITY (2011)
Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy
Katarina Berinder et al.
PITUITARY (2011)
Dopamine Receptors in Human Adipocytes: Expression and Functions
Dana C. Borcherding et al.
PLOS ONE (2011)
Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma
Cihangir Erem et al.
CLINICAL ENDOCRINOLOGY (2010)
Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk
Marco C. Amato et al.
DIABETES CARE (2010)
Bromocriptine: old drug, new formulation and new indication
R. I. G. Holt et al.
DIABETES OBESITY & METABOLISM (2010)
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Beverly M. K. Biller et al.
BMC ENDOCRINE DISORDERS (2010)
Prolactin and Preclinical Atherosclerosis in Menopausal Women With Cardiovascular Risk Factors
George A. Georgiopoulos et al.
HYPERTENSION (2009)
Hypoprolactinemia: A New Clinical Syndrome in Patients with Sexual Dysfunction
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2009)
The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia
Huriye Balci et al.
PITUITARY (2009)
Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique
Alpaslan Tuzcu et al.
PITUITARY (2009)
Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
Freddy Contreras et al.
AMERICAN JOURNAL OF THERAPEUTICS (2008)
Induction of central leptin resistance in hyperphagic pseudopregnant rats by chronic prolactin infusion
Rachael A. Augustine et al.
ENDOCRINOLOGY (2008)
Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women
Petra Kok et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes
Eric R. Hugo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Body fat in men with prolactinoma
E. C. O. Naliato et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Body fat in nonobese women with prolactinoma treated with dopamine agonists
Erika C. O. Naliato et al.
CLINICAL ENDOCRINOLOGY (2007)
Adipocyte prolactin: regulation of release and putative functions
T. Brandebourg et al.
DIABETES OBESITY & METABOLISM (2007)
Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy
Anthony J. Weinhaus et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Advances in the treatment of prolactinomas
Mary P. Gillam et al.
ENDOCRINE REVIEWS (2006)
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
O Serri et al.
CLINICAL ENDOCRINOLOGY (2006)
Focus on prolactin as a metabolic hormone
N Ben-Jonathan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males
M De Rosa et al.
CLINICAL ENDOCRINOLOGY (2006)
Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion
B Rubí et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Outcome of cabergoline treatment in men with prolactinoma: Effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Prolactin release is enhanced in proportion to excess visceral fat in obese women
P Kok et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Distinctive roles for prolactin and, growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of Langerhans
TC Brelje et al.
ENDOCRINOLOGY (2004)
Insulin sensitivity and hyperprolactinemia
A Tuzcu et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2003)
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia
A Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia
J Korner et al.
OBESITY RESEARCH (2003)
Changes in agouti-related peptide during the ring dove breeding cycle in relation to prolactin and parental hyperphagia
AD Strader et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine
M Doknic et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Bromocriptine - A novel approach to the treatment of type 2 diabetes
H Pijl et al.
DIABETES CARE (2000)
Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia
RC Vasavada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Body weight gain after administration of antipsychotic drugs:: Correlation with leptin, insulin and reproductive hormones
T Baptista et al.
PHARMACOPSYCHIATRY (2000)
Prolactin induction of insulin gene expression: the roles of glucose and glucose transporter-2
A Petryk et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice
KG Bina et al.
NEUROENDOCRINOLOGY (2000)
分享论文
